Pfizer and Moderna could score $32 billion in Covid-19 vaccine sales -- in 2021 alone
The imminent authorization of Pfizer's Covid-19 vaccine in the United States is a momentous occasion for science, the economy and humanity. The milestone is also a major moneymaker…